Cervarix cervical cancer vaccine reimbursed at 65%
The vaccines protection Cancer of the cervix are a revolution for women's health. And just after competitor Gardasil (Merck-Sanofi Pasteur), the vaccine Cervarix, intended to prevent Cancer of the cervix, is now reimbursed by Social Security. Developed by GlaxoSmithKline (GSK), this vaccine obtained its marketing authorization in 2007.
The conditions to be refunded? Being a young woman aged 14 to 23 who has not yet had sex.
The price of Cervarix is close to Gardasil, about 145? the dose. Vaccination against Cancer of the cervix requires three injections, a total of 435 ?. The cost to the patient, after reimbursement, would be about 152?
Getting vaccinated is important because in France, doctors detect 3,400 new cases of Cancer of the cervix and report 1,000 deaths each year. Cervical lesions are the second leading cause of death Cancer at the woman.
The conditions to be refunded? Being a young woman aged 14 to 23 who has not yet had sex.
The price of Cervarix is close to Gardasil, about 145? the dose. Vaccination against Cancer of the cervix requires three injections, a total of 435 ?. The cost to the patient, after reimbursement, would be about 152?
Getting vaccinated is important because in France, doctors detect 3,400 new cases of Cancer of the cervix and report 1,000 deaths each year. Cervical lesions are the second leading cause of death Cancer at the woman.
